Bruker Corporation and Switzerland-based Biognosys AG have announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Click to read more.
Bruker Corporation and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan acted as exclusive financial advisor to Biognosys.
New strategic partnership aims to broaden access to Biognosys' leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics